MedPath

"Effect examination of infliximab to the effect insufficient example and the example of effect decrease of the 1st TNF inhibitor in rheumatoid arthritis "

Not Applicable
Completed
Conditions
Rheumatoid Arthritis
Registration Number
JPRN-UMIN000007786
Lead Sponsor
Saitama Medical Center. Saitama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

"1) The patient who is having infliximab medical treatment already experienced 2) The patient who cannot prescribe a methotrexate tablet for the patient 3) The patient who is experienced in TNF inhibitors as for more than 2 agent 4) In addition, the patient who judged that a research doctor was unsuitable "

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the remission rate of 1-2years after(DAS28(4)-CRP<2.3 or DAS28(4)-ESR<2.6 or SDAI<3.3 or CDAI<2.8)
Secondary Outcome Measures
NameTimeMethod
the low disease activity maintenance rate of 1-2 years after (DAS28(4)-ESR<3.2 or SDAI<11 or CDAI<10 the low disease activity maintenance rate of 1-2 years after (DAS28(4)-ESR<3.2 or SDAI<11 or CDAI<10
© Copyright 2025. All Rights Reserved by MedPath